Fundz Deep Dive
Everything you need to win Oncolytics Biotech — in one platform.
Who to reach, what to say, and why now on Oncolytics Biotech — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Oncolytics Biotech — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital
Apr 10, 2025•about 1 year ago
Contract Type
partnership
CalgaryBiotechnologyHealth CareDescription
Oncolytics Biotech® Inc. has entered into a share purchase agreement (SPA) with Alumni Capital LP to provide funding for the ongoing clinical development of pelareorep. This partnership will enable Oncolytics to progress toward key clinical milestones and minimize dilution to create and sustain shareholder value.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months